EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Socioeconomic Status and Access to Treatment in Diffuse Large B‐Cell Lymphoma

Kuitunen Joonas iD, Marin Katja iD, Tokola Susanna iD, Pollari Marjukka iD, Jyrkkiö Sirkku iD, Suominen Minna, Partanen Anu iD, Vuolukka Kristiina iD, Sunela Kaisa iD, Rönkä Aino iD, Aromaa-Häyhä Annikki iD, Klaavuniemi Tuula und 4 weitere

Cancer Medicine · 2026

DOI: 10.1002/cam4.71920 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Kuitunen Joonas und 15 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Health Services Accessibility, Social Class. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Large B‐cell lymphoma (LBCL) is the most common lymphoma subtype, with diffuse LBCL (DLBCL) accounting for 30%–40% of new lymphoma cases. The International Prognostic Index (IPI) is widely used for prognostic assessment in DLBCL. Clinical features associated with a poorer prognosis, such as advanced disease stage, could be a consequence of delayed diagnosis, which in turn may be influenced by a patient's socioeconomic status. While healthcare in Finland aims to ensure equal access to timely and high‐quality treatment for all, disparities still exist. In this study we evaluated the impact of patients' socioeconomic status on their access to diagnostic procedures. Patient/Material and Methods Patient data was prospectively collected from seven hospitals between October 2014 and March 2020 in Finland. A total of 160 patients provided information regarding their diagnostic pathway and socioeconomic status via questionnaire. The data was combined with clinical data from patient records.

Results

The symptoms to treatment interval (STI) varied between age groups ( p = 0.019), marital status groups ( p = 0.023), and healthcare providers. In addition, age, income level, and occupational status (all p < 0.001) influenced which healthcare provider patients used as their first place of contact.

Interpretation

In this prospective study, we analyzed the impact of patients' socioeconomic status on treatment delays within the treatment pathway. Socioeconomic status was found to have a significant effect on these delays. The delays varied not only between different socioeconomic groups but also across different healthcare providers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseHealth Services AccessibilitySocial ClassHumansFemaleFinlandMaleMiddle AgedProspective StudiesAgedAdultTime-to-TreatmentTreatment DelayPrognosisAged, 80 and overSocioeconomic Disparities in Health

Stichwörter der Autor:innen

delayed diagnosisdiffusehealth care disparitieshealth services accessibilitylarge B‐celllymphomasocioeconomic factors

Autor:innen und Institutionen

  • Faculty of Health Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
  • Department of Clinical Oncology, Kuopio University Hospital, Kuopio, Finland.
  • Cancer Centre, Oulu University Hospital, Oulu, Finland.
  • Department of Oncology and Radiotherapy, Tampere University Hospital, Tampere, Finland.
  • The Wellbeing Services County of Southwest Finland, Turku University Hospital, Turku, Finland.
  • North Karelia Central Hospital, Joensuu, Finland.

ORCID-Profile: Kuitunen Joonas, Marin Katja, Tokola Susanna, Pollari Marjukka, Jyrkkiö Sirkku, Partanen Anu, Vuolukka Kristiina, Sunela Kaisa, Rönkä Aino, Aromaa-Häyhä Annikki, E L Kuusisto Milla, Kuitunen Hanne, Kuittinen Outi

Zitieren

APA

Joonas, K., Katja, M., Susanna, T., Marjukka, P., Sirkku, J., Minna, S., Anu, P., Kristiina, V., Kaisa, S., Aino, R., Annikki, A. H., Tuula, K., Anna, H., Milla, E. L. K., Hanne, K., & Outi, K. (2026). Socioeconomic Status and Access to Treatment in Diffuse Large B‐Cell Lymphoma. Cancer Medicine. https://doi.org/10.1002/cam4.71920

Vancouver

Joonas K, Katja M, Susanna T, Marjukka P, Sirkku J, Minna S, et al. Socioeconomic Status and Access to Treatment in Diffuse Large B‐Cell Lymphoma. Cancer Medicine. 2026. doi:10.1002/cam4.71920

BibTeX
@article{Joonas2026,
  author = {Joonas, Kuitunen and Katja, Marin and Susanna, Tokola and Marjukka, Pollari and Sirkku, Jyrkkiö and Minna, Suominen and Anu, Partanen and Kristiina, Vuolukka and Kaisa, Sunela and Aino, Rönkä and Annikki, Aromaa-Häyhä and Tuula, Klaavuniemi and Anna, Hakalahti and Milla, E L Kuusisto and Hanne, Kuitunen and Outi, Kuittinen},
  title = {Socioeconomic Status and Access to Treatment in Diffuse Large B‐Cell Lymphoma},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71920}
}
Kostenlos starten →